Dollar Tree (DLTR) stock dropped 3.8% despite beating Q4 earnings estimates, as conservative Q1 and full-year guidance disappointed investors. The post Dollar TreeDollar Tree (DLTR) stock dropped 3.8% despite beating Q4 earnings estimates, as conservative Q1 and full-year guidance disappointed investors. The post Dollar Tree

Dollar Tree (DLTR) Stock Slides on Weak Guidance Despite Q4 Earnings Win

2026/03/16 20:41
3 min read
For feedback or concerns regarding this content, please contact us at [email protected]

TLDR

  • Q4 adjusted earnings per share reached $2.56, surpassing the $2.53 analyst estimate
  • Revenue climbed 9% year-over-year to $5.45 billion with 5% comparable sales growth
  • First-quarter outlook for earnings and revenue fell short of analyst projections
  • Annual EPS forecast of $6.50–$6.90 brackets the $6.70 consensus estimate
  • Shares declined approximately 3.8% in Monday trading after the earnings release

Dollar Tree (DLTR) delivered fourth-quarter results that topped expectations Monday, yet shares retreated as management issued conservative projections for upcoming periods.

The value retailer announced adjusted earnings of $2.56 per share for the quarter that concluded January 31, narrowly exceeding the $2.53 Street consensus. This represented a dramatic reversal from the prior-year period when the company registered a loss of $17.17 per share.


DLTR Stock Card
Dollar Tree, Inc., DLTR

Revenue for the period totaled $5.45 billion, representing a 9% year-over-year increase and meeting analyst expectations. Comparable store sales advanced 5%, slightly ahead of the 4.9% consensus projection.

The comparable sales improvement stemmed from a 6.3% increase in average transaction value. However, customer traffic declined 1.2% — indicating shoppers purchased more during each visit, though store visits decreased overall.

CEO Mike Creedon highlighted the company’s achievement of 20 straight years of positive comparable sales growth, demonstrating the retailer’s enduring appeal as a value-focused shopping destination.

Guidance Misses the Mark

The forward-looking projections presented challenges for investors. Dollar Tree issued Q1 adjusted EPS guidance of $1.45 to $1.60, producing a midpoint of $1.52. Wall Street had anticipated $1.56.

Revenue guidance for the first quarter ranged from $4.9 billion to $5.0 billion, compared to the $4.96 billion analyst consensus. Management projected comparable sales growth of 3% to 4%, below the 3.6% Street estimate.

For the complete fiscal year, the retailer forecasts adjusted earnings per share between $6.50 and $6.90 on revenue of $20.5 billion to $20.7 billion. Analyst consensus stood at $6.70 for EPS and $20.66 billion for sales — both falling within the guided range but leaning toward the lower end.

Dollar General Set a Similar Tone

Dollar Tree’s cautious stance mirrors that of competitor Dollar General, which released earnings last week and similarly projected modest sales growth for the upcoming year.

Dollar General attributed recent winter weather disruptions as headwinds for the current quarter. The company also noted broader uncertainties surrounding consumer spending patterns.

Dollar Tree shares fell 3.8% during Monday’s session. Dollar General stock posted modest gains on the same day.

During premarket hours, Dollar Tree shares recovered some ground and traded near flat levels before the opening bell. Earlier in the session, the stock had declined as much as 2.6% to $104.63.

The Q4 performance represents a significant turnaround from the year-earlier quarter, when Dollar Tree posted a net loss of $3.7 billion — primarily driven by extraordinary charges.

This quarter’s net income reached $506.1 million, translating to $2.53 per share on a GAAP basis.

The post Dollar Tree (DLTR) Stock Slides on Weak Guidance Despite Q4 Earnings Win appeared first on Blockonomi.

Market Opportunity
Treehouse Logo
Treehouse Price(TREE)
$0.06954
$0.06954$0.06954
+0.87%
USD
Treehouse (TREE) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact [email protected] for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.
Tags:

You May Also Like

And the Big Day Has Arrived: The Anticipated News for XRP and Dogecoin Tomorrow

And the Big Day Has Arrived: The Anticipated News for XRP and Dogecoin Tomorrow

The first-ever ETFs for XRP and Dogecoin are expected to launch in the US tomorrow. Here's what you need to know. Continue Reading: And the Big Day Has Arrived: The Anticipated News for XRP and Dogecoin Tomorrow
Share
Coinstats2025/09/18 04:33
Swiss Franc Intervention: Critical Analysis of SNB’s 2025 Policy and Safe-Haven Resilience

Swiss Franc Intervention: Critical Analysis of SNB’s 2025 Policy and Safe-Haven Resilience

BitcoinWorld Swiss Franc Intervention: Critical Analysis of SNB’s 2025 Policy and Safe-Haven Resilience ZURICH, March 2025 – The Swiss National Bank faces mounting
Share
bitcoinworld2026/03/16 23:10
Cashing In On University Patents Means Giving Up On Our Innovation Future

Cashing In On University Patents Means Giving Up On Our Innovation Future

The post Cashing In On University Patents Means Giving Up On Our Innovation Future appeared on BitcoinEthereumNews.com. “It’s a raid on American innovation that would deliver pennies to the Treasury while kneecapping the very engine of our economic and medical progress,” writes Pipes. Getty Images Washington is addicted to taxing success. Now, Commerce Secretary Howard Lutnick is floating a plan to skim half the patent earnings from inventions developed at universities with federal funding. It’s being sold as a way to shore up programs like Social Security. In reality, it’s a raid on American innovation that would deliver pennies to the Treasury while kneecapping the very engine of our economic and medical progress. Yes, taxpayer dollars support early-stage research. But the real payoff comes later—in the jobs created, cures discovered, and industries launched when universities and private industry turn those discoveries into real products. By comparison, the sums at stake in patent licensing are trivial. Universities collectively earn only about $3.6 billion annually in patent income—less than the federal government spends on Social Security in a single day. Even confiscating half would barely register against a $6 trillion federal budget. And yet the damage from such a policy would be anything but trivial. The true return on taxpayer investment isn’t in licensing checks sent to Washington, but in the downstream economic activity that federally supported research unleashes. Thanks to the bipartisan Bayh-Dole Act of 1980, universities and private industry have powerful incentives to translate early-stage discoveries into real-world products. Before Bayh-Dole, the government hoarded patents from federally funded research, and fewer than 5% were ever licensed. Once universities could own and license their own inventions, innovation exploded. The result has been one of the best returns on investment in government history. Since 1996, university research has added nearly $2 trillion to U.S. industrial output, supported 6.5 million jobs, and launched more than 19,000 startups. Those companies pay…
Share
BitcoinEthereumNews2025/09/18 03:26